Potential Mechanisms Underlying Inflammation-Enhanced Aminoglycoside-Induced Cochleotoxicity
Aminoglycoside antibiotics remain widely used for urgent clinical treatment of life-threatening infections, despite the well-recognized risk of permanent hearing loss, i.e., cochleotoxicity. Recent studies show that aminoglycoside-induced cochleotoxicity is exacerbated by bacteriogenic-induced infla...
Main Authors: | Meiyan Jiang, Farshid Taghizadeh, Peter S. Steyger |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2017-11-01
|
Series: | Frontiers in Cellular Neuroscience |
Subjects: | |
Online Access: | http://journal.frontiersin.org/article/10.3389/fncel.2017.00362/full |
Similar Items
-
Topical gentamicin-induced acute vestibulopathy: A case report
by: Teik Beng Lau, et al.
Published: (2023-05-01) -
Preferential Cochleotoxicity of Cisplatin
by: Pattarawadee Prayuenyong, et al.
Published: (2021-07-01) -
Local Mechanisms for Loud Sound-Enhanced Aminoglycoside Entry into Outer Hair Cells
by: Hongzhe eLi, et al.
Published: (2015-04-01) -
CDK2 regulates aminoglycoside-induced hair cell death through modulating c-Jun activity: Inhibiting CDK2 to preserve hearing
by: Litao Tao, et al.
Published: (2022-10-01) -
Development of Tinnitus and Hyperacusis in a Mouse Model of Tobramycin Cochleotoxicity
by: Ryan J. Longenecker, et al.
Published: (2021-09-01)